• Careers
  • Investors
  • Our Responsibility
  • News
  • Partners
  • Contact Us
Find
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Products Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Protecting the Environment
    • Protecting Our People
    • Access to Medicines
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • Investor Relations
    • Annual Reports & Proxy
    • Awards & Recognition
    • Company Information
    • Corporate Governance
    • Financial Information
    • News Releases
    • Pharmaceutical/Medical Devices and Diagnostics Pipeline
    • SEC Filings
    • Shareholder Services
    • Stock Information
    • Webcasts & Presentations
    • Investor Tools
    • Investor Contacts
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Investor Relations


Featured Events

Johnson & Johnson Fourth Quarter and Full Year 2011 Earnings Meeting and Webcast
January 24, 2012
8:30 AM ET


Stock Symbol JNJ
Current Price $65.24
Change $-0.02
Day High $65.35
Day Low $65.09
Volume 6,825,500
Trades 30,764
02/08/2012 4:01 PM
Minimum 20 mins delay.

Stock Transfer Agent
Computershare
1-800-328-9033
or
781-575-2718
outside the U.S. and Canada


Investing in Johnson & Johnson

Johnson & Johnson has been a part of people's lives for 125 years and a valuable part of their investments for more than 65 years. Founded in 1886, we listed our shares on the New York Stock Exchange for public investors in 1944.

During our history, we have built the most comprehensive base of health care businesses in the world, generating approximately 70 percent of our revenues from No. 1 or No. 2 global leadership positions in our respective markets.

Our consistent performance has enabled us to deliver an exceptional track record of growth that few, if any, companies can claim: 27 consecutive years of adjusted earnings increases; and 49 consecutive years of dividend increases. Over the last 10 years, Johnson & Johnson stock generated a 4.0 percent total return for investors compared to a 1.4 percent total return for the S&P 500.(1)

Our consumer products, pharmaceuticals, medical devices and diagnostics play a role in helping millions of people be well and stay well every day. We remain committed to improving the health and well-being of people everywhere, profitably growing our businesses, and enhancing the value we can bring to our shareholders.



E-Delivery of Annual Meeting and Proxy Materials

Johnson & Johnson is dedicated to improving the health and well-being of people everywhere. To fulfill this goal, we must protect the environments in which we work and live. A healthy planet and a healthy community go hand in hand. With this in mind, we now offer electronic versions of all of our company publications like the Annual Report.


Click here for the on-line Annual Report
Click here for the Proxy Materials

Show   Additional Information

You can do your part as well. By reducing the amount of printed shareholder materials you receive, you can help protect the environment while quickly receiving important shareholder documents. In addition, reducing the printing and mailing costs associated with more traditional delivery methods allows us to control expenses in the interest of delivering more value for all our shareholders.

Registered Johnson & Johnson shareholders can sign up for electronic delivery of our reports and publications. Please go to www.computershare-na.com/green or contact our transfer agent, Computershare, at 1-800-328-9033.

Beneficial (owned through a broker/bank) Johnson & Johnson shareholders can register for on-line delivery of materials by clicking here and following the easy directions to your account.

Click here to see other financial documents and publications that can be electronically downloaded.


Investor News

January 24, 2012
Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:

January 17, 2012
Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results

January 3, 2012
Johnson & Johnson Announces First-Quarter 2012 Quarterly Dividend

Investor Communications

January 24, 2012 at 8:30 AM ET
Johnson & Johnson Fourth Quarter and Full Year 2011 Earnings Meeting and Webcast

Financial Quick Links

Q4 2011 Earnings Announcement

Q4 2011 Sales of Key Products/Franchises

5 Year Financial Review


1. Data source - Bloomberg

  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc. 1997-2012. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partners
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Our Management Approach

  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.
All contents © Johnson & Johnson Services, Inc. 1997-2012. All Rights Reserved.